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I have explored the use of the matrix assisted pulsed laser evaporation (MAPLE) 
and MAPLE direct write (MDW) to create thin films of biological materials.  MAPLE is 
a novel physical vapor deposition technique used to deposit thin films of organic 
materials. The MAPLE process involves the laser desorption of a frozen dilute solution 
(1-5%) containing the material to be deposited.  A focused laser pulse (~200 mJ/cm2) 
impacts the frozen target, which causes the solvent to preferentially absorb the laser 
energy and evaporate.  The collective action of the evaporated solvent desorbs the 
polymeric solute material towards the receiving substrate placed parallel and opposite to 
the target.  The bioresorbable polymer PDLLA and the anti-inflammatory pharmaceutical 
dexamethasone were processed using MAPLE, and characterized using Fourier transform 
infrared spectroscopy, atomic force microscopy and x-ray photoelectron spectroscopy.  
MDW is a CAD/CAM controlled direct writing process.  The material to be transferred is 
immersed in a laser-absorbing matrix or solution and coated onto a target or support 
positioned microns to millimeters away from a receiving substrate.  Using a UV 
microscope objective, a focused laser pulse is directed at the backside of the ribbon, so 
that the laser energy first interacts with the matrix at the ribbon/matrix interface.  This 
energy is used to gently desorb the depositing material and matrix onto the receiving 
substrate. I have deposited neuroblasts within a three-dimensional extracellular matrix 
sheet (~75µm).  These two laser processing techniques have enormous potential for 




 Chapter 1. Introduction 
1.1 Background 
Since their invention in the early 1960s, lasers have had many uses in the medical 
field. Lasers are ideal for removing unwanted tissue, because they are able to direct high 
energy radiation of a single wavelength onto a focused location. Most current medical 
uses of lasers fall under the use of the laser as a “universal scalpel” in minimally invasive 
surgeries, which offer little contact, little blood loss, shorter operating times, and less 
postoperative pain than conventional techniques. Laser in situ keratomileusis (LASIK) 
refractive corneal surgery, coagulation for retinal detachment, and skin treatments are 
only some of the current applications for lasers in medicine. Lasers-tissue interaction may 
also provide a characteristic luminescence that is useful in sensing blood flow, oxygen 
concentration, and pH within tissue.  
In the future, lasers may serve to create novel medical devices with unique 
biological functionalities. For example, lasers offer a unique opportunity for nanoscale 
processing of materials. Nanostructured biosensors, drug delivery devices, tissue 
scaffolds, and membranes may provide the capability for specific interactions with 
proteins, DNA, viruses, and other biological structures. In this manuscript, I will discuss 
the current status of the laser processing methods: matrix assisted pulsed laser 
evaporation (MAPLE) and matrix assisted pulsed laser evaporation direct write (MDW), 
for the development of drug delivery thin films, and cells deposited three-dimensionally 




1.2 Matrix Assisted Pulsed Laser Evaporation (MAPLE) 
Today, there is a great need for depositing high quality organic and polymer thin 
films, multilayers, and composites.  Moreover, there is a need for a method that can 
maintain strict tolerances on the structural, morphological, and chemical composition of 
the film. For example, in biological and chemical sensor applications, high quality thin 
films of chemoselective or bioselective materials must be processed so that the 
physiochemical properties are maintained.  Current implantable medical devices, such as 
artificial hip prosthesis, catheters, and pacemakers typically need to be coated with a 
passivation layer to protect the devices from interaction with bodily fluid that may cause 
corrosion or degradation.  Next generation medical devices will likely contain multi-layer 
coatings along with some type of pharmacological agent or growth factor. Possible 
coating materials for such an application may be synthetic (poly D, L lactide) or natural 
(chitosan) polymers.  In both cases, these films must be processed by a technique that 
will not damage the materials, and allow strict control of the film characteristics. 
  To fully exploit the bulk properties of natural and synthetic polymers, the thin 
film must mimic these attributes.  Physical vapor deposition (PVD) techniques that 
successfully deposit more robust materials such as metals will not work because the 
organic or polymer material is too fragile for this process.  Solvent-based coating 
technologies, such as spin-coating, dip-coating and drop-casting, typically result in 
inhomogeneous films with difficult thickness control and are restricted to single layers.  
However, some attributes of PVD processes would be highly beneficial in depositing 
high quality organic and polymeric thin films.  For instance, layer-by-layer growth, 
control thickness, clean interfaces, and dry processing in PVD and material salvation in 
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solvent coating techniques would be ideal attributes of an organic or polymer thin film 
deposition technique.  Matrix assisted pulsed laser evaporation (MAPLE) is a thin film 
deposition technique, which uses aspect from both PVD and solvent coating techniques.  
A diagram explaining the overlapping of these three techniques is shown in Figure 1. 
 
 
Figure 1.  A comparison of the overlapping characteristics of physical vapor deposition, 
solvent casting/coating and MAPLE. 
 
MAPLE is a novel physical vapor deposition technique used to deposit thin films 
of polymeric, biologic, pharmacologic and other fragile organic materials onto a 
substrate. [1,2]  A schematic diagram of the MAPLE deposition process is shown in 
Figure 2.  The MAPLE process involves the laser desorption of a frozen dilute solution 
(1-5%) containing the material to be deposited.  The laser-material interaction in MAPLE 
has been described as a photothermal process. [1]  A focused laser pulse (~200 mJ/cm2) 
impacts the frozen target, and the photon energy absorbed by the solvent is converted into 
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thermal energy, causing the solvent to evaporate.  As the surface solvent molecules are 
vaporized, polymer molecules become exposed to the gas-target matrix interface.  
Through collisions with the evaporating solvent molecules, the polymer molecules attain 
enough kinetic energy to be transferred into the gas phase.  The collective action of the 
evaporated solvent desorbs the polymeric solute material towards the receiving substrate 
placed parallel and opposite to the target.  As deposition takes place in a vacuum chamber 
onto a room temperature substrate, the evaporated volatile solvent is not absorbed in the 
film and rapidly pumped away. Through careful optimization of MAPLE deposition 
conditions, deposition can occur without any significant polymer decomposition, e.g., for 
polymers this means minimal to no reduction in the degree of polymerization chemical 
modification or loss of functional groups. [1] The MAPLE process proceeds layer-by-
layer, depleting solvent and polymer in the same concentration as the starting solution.  
The advantage of MAPLE is that it has the important attributes of a dry physical vapor 
deposition technique like sputtering or e-beam evaporation, yet it handles the fragile 
material in a solvated state.   
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Figure 2.  Schematic of the MAPLE deposition process 
 
One of the original applications for the MAPLE technique was the deposition of 
thin, homogenous films of a chemoselective polymer used on sensing platforms such as 
surface acoustic wave devices.[3]  Since this initial experiment, MAPLE has been used to 
deposit a wide range of organics and polymers.  Various carbohydrates, such as sucrose, 
glucose and dextran have been deposited. [4]  Biocompatible polymers thin films of 
polyethylene glycol (PEG) have also been successfully deposited. [5]  More recently, the 
need has developed for the growth of biomaterial thin films for the development of next-
generation biosensors or biochips, drug delivery, and coatings for medical devices.  
Deriving from this need, fragile organic thin films of horseradish peroxidase [6], type I 
collagen [7], bovine serum albumin and phospholipid polymers [8] have been produced 




1.3 Matrix Assisted Pulsed Laser Evaporation Direct Write (MDW) 
Direct writing is a powerful approach to fabricate patterns of material that are 
completely CAD/CAM controlled and do not rely on various masks or molds.  Derived 
from the need to rapid construct electronic devices, many different direct writing 
techniques were first used to direct write passive electronics.  Of these processes, laser 
forward transfer is one approach that is especially flexible because: optical imaging is 
built into the system, transfer is possible for any material, and this technique can rapidly 
fabricate as well as provide laser annealing, cleaning, and micro machining.  Although 
lasers are not typically associated with construction of materials, they can be a gentle 
method to transfer and process materials. 
 
 
Figure 3. Schematic of the LIFT process. 
 
Laser induced forward transfer (LIFT) is a very simple approach to direct writing 
materials (Figure 3).  The LIFT technique requires a thin film (about 200 nm) deposited 
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onto a laser transparent support to be pressed slightly to a receiving substrate. [9]  Pulsed 
laser shots pass through the laser transparent support to atomize the thin film on the 
opposite side and deposit the coated material onto the receiving substrate.  Originally, 
this method was successful in depositing metal [10,11] and inorganic [12] thin films; 
however, the design setup had to be slightly modified to extend the capabilities of the 
LIFT process to transfer a wider range of materials and at a higher deposition rate.  A 
schematically similar technique to LIFT, termed matrix assisted pulsed laser evaporation 
direct write (MDW), was developed to more gently deposit materials without excessive 
heating of the surrounding material. 
MDW is a CAD/CAM controlled direct writing process that is schematically 
similar to LIFT because the material to be transferred is immersed in a laser-adsorbing 
matrix or solution and coated onto a target or support.  However, in MDW, the transfer 
support, or “ribbon,” is not coated with a metal absorbing layer and it is positioned 
microns to millimeters away from a receiving substrate.  Using a UV microscope 
objective, a focused laser pulse is directed at the backside of the ribbon, so that the laser 
energy first interacts with the matrix at the ribbon/matrix interface.  This energy is used 
to gently desorb the depositing material and matrix onto the receiving substrate.  To 
deposit patterns, a computer program controls the motion of an X-Y transition stage, 
which controls the lateral and longitudinal movement of both the ribbon and receiving 





Figure 4.  Schematic of the MAPLE Direct Write process.  
 
MDW was originally designed as a method to rapidly construct electronic devices 
such as interconnects, resistors, and capacitors. [13,14]  MDW has been used to deposit 
metals, ceramic powders, nano-powders, and organometallic precursors using an 
experimental set-up similar to LIFT, but by coating the transparent ribbon with solvated 
materials it was mechanistically different.  The laser-solvent material interaction resulted 
in a matrix-assisted transfer similar to the vacuum MAPLE process. [15]  MDW was able 
to transfer organic and polymeric materials for the fabrication of gas sensor chemi-
resistors [13] and chemical sensors [16].  MDW was also used as a fabrication method to 
deposit more sensitive materials such as proteins and living cells for the construction of 
protein microarrays [17] and tissue based sensors. [8]  In 2001, Ringeisen et al. were able 
to transfer viable Chinese hamster ovaries. [6]  MDW has also had success depositing 
embryonal carcinoma [18], rat cardiac [1], and human osteoblast cells. [8] 
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In MDW, the UV laser irradiation must be totally attenuated in the solvent 
otherwise the radiation may genetically alter the cells.  It is well known that UV 
irradiation of biological materials can be irreversibly destructive causing DNA damage.  
Any processing technique used in a medical setting should not create new health 
problems in an attempt to eliminate others. Preliminary mutagenicity studies have 
fortunately shown no evidence of DNA strand breakage. An initial neutral comet assay 
on transferred p19 cells found no evidence of double strand breaks. [18]  In my research, 
a follow up comet assay also showed that transferred neuroblasts did not undergo 
apoptotic DNA double strand breaks. It is possible that cytoplasmic proteins within the 















Chapter 2. MAPLE Deposition of PDLLA/Dexamethasone Bilayers 
2.1 Introduction 
It has been estimated that at least 40 million people worldwide suffer from 
epilepsy and 1 in 20 people will have an epileptic seizure. [19]  Epilepsy is a brain 
disorder in which clusters of neurons in the brain signal abnormally.  This disruption of 
electrical signals in the brain leads to seizures.  However, once epilepsy is diagnosed, 
seizures can be controlled with medicine and monitored with surgical techniques such as 
electroencephalography. 
Electroencephalography, or EEG, is a neurological test that uses an electrical 
monitoring device to measure electrical activity in the brain.  EEG is a key tool in the 
diagnosis and management of epilepsy and other seizure disorders. [20]  It is also used as 
a diagnostic tool for patients suffering from mental retardation, sleep disorders and 
various degenerative diseases such as Alzheimer’s disease. [21]  For a patient undergoing 
EEG, electrodes can be attached to the patients scalp; however, depending on the purpose 
for the EEG, implantable or invasive electrodes are necessary. One significant drawback 
of using invasive electrodes, which are surgically inserted into the brain, is the risk of 
scarring. [22] 
Any neural implants inserted into the brain cause tissue injury, which initiates a 
series of cellular and molecular events. [23] Histological evidence shows that a cellular 
sheath surrounds the insertion site of Si microelectrodes, which is a typical consequence 
of inflammatory reaction resulting from physical injury to the central nervous system 
(CNS). [24] In the CNS, this process of sheath formation is termed “reactive gliosis” or 
astroglial scarring.  The glial scar forms an inhibitory barrier preventing axon re-growth 
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and functions as a diffusive barrier that is thought to reduce the ability of implanted 
devices to communicate with neurons by insulating the device from the surrounding brain 
tissue. [25]  To maintain long-term recording stability, reactive gliosis and other 
inflammatory processes around the electrode need to be minimized [26]. 
We propose a novel method of neuronal implant drug coating, which involves 
using MAPLE to coat the implant with single or multiple bilayers of a biodegradable 
polymer covering an inflammatory pharmaceutical.  Depositing a uniform polymer/drug 
thin film multilayer coating onto the implant surface would slow the absorption of the 
drug thereby delivering a more sustained anti-inflammatory pharmaceutical dosage.  
Poly D, L lactide or PDLLA is a polymer derived from the optically active D and 
L monomers of PLA. The chemical structure of this biodegradable polyester is shown in 
Figure 5.  PDLLA degrades faster than PLA, the homopolymer of L-lactic acid, because 
it is amorphous. Since PDLLA is amorphous, it is more likely to exhibit a homogeneous 
dispersion of the active species within a monophasic matrix.  PDLLA degradation occurs 
via chain scission, during which polymer chains are cleaved to form oligomers and then 
monomers.  The erosion process can be described as the loss of oligomers and monomers 
leaving the polymer film.  Degradation of these lactide based polymers and other 




Figure 5.  PDLLA chemical structure.  
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Dexamethasone is in the class of drugs known as glucocorticoids, which are 
known to inhibit cellular inflammation processes as well as prevent smooth muscle cell 
proliferation and collagen formation. [27] Glucocorticoids inhibit some of the 
mechanisms involved in cell-mediated immunologic functions, especially those 
dependent on lymphocytes.  They also have a dramatic effect on the distribution and 
function of leukocytes. Specifically, dexamethasone is known to regulate T-cell survival, 
growth and differentiation.  As a locally delivered therapeutic, dexamethasone is an ideal 
drug coating for use on medical implants.  Local delivery is also advantageous because 
systematic exposure to glucocorticoids can result in toxicity including adrenal 
suppression, metabolic effects (growth inhibition, diabetes, and osteoporosis), salt 
retention, and psychosis. [27]  The chemical structure of dexamethasone is shown in 
figure 6.   
 
Figure 6.  Chemical structure of dexamethasone. 
 
Following neural electrode insertion, microglia mediate the initial inflammatory 
response to brain injury.  Microglia produce inflammatory molecules such as nitric oxide, 
IL-1β, TNF α, which induce neuronal cell death and trigger the activation of astrocytes, 
which finally result in glial scar formation. [28-30]  Dexamethasone is a corticosteroid 
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with potent anti-inflammatory properties, which has been widely used clinically for 
treatment of inflammation or immune response as well as chronic inflammatory 
disorders.  Most importantly, dexamethasone has been previously shown to inhibit 
microglia proliferation, NO production, and cytokine secretion. [31]  
We have demonstrated successful deposition of PDLLA thin films on ZnSe 
substrates and PDLLA/dexamethasone bilayer films on SiO2.  Using Fourier transform 
infrared spectroscopy, atomic force microscopy, and X-ray photoelectron spectroscopy, 
we have shown that our PDLLA/dexamethasone films were deposited with micro-scale 
smoothness and maintained their chemical structure post-transfer.  Additionally, we have 
also shown that dexamethasone maintained its bioactivity post transfer.   
 
2.2 Materials and Methods 
2.2.1 Material Sourcing 
PDLLA was commercially obtained (Sigma Aldrich, St. Louis, MO).  The 
manufacturer’s listed molecular weight is 75,000-120,000.  To create a suitable MAPLE 
target matrix, the PDLLA was solvated into a 4% g/ml solution with ethyl acetate (Fisher 
Scientific, Hampton, NH).  Dexamethasone (Sigma Aldrich, St. Louis, MO) was solvated 
into 2% g/ml solution using ethyl acetate.  The manufacturor’s listed molecular weight 
for dexamethasone is 392.46.   
2.2.2 Matrix Assisted Pulsed Laser Evaporation 
MAPLE depositions of each material were performed using a pulsed Lambda 
Physik ArF laser (λ=193 nm, τFWHM=30 ns, pulse rate=20 Hz, laser fluence=600-1000 
mJ/cm2). The incident angle of the laser beam was placed at an angle of 45o with respect 
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to the normal of the target surface. The target-substrate distance was maintained at 70 
mm, and the spot area was maintained between 2.5-3.5 mm2. Prior to deposition, ~1 ml of 
the solvated fluid was pipetted into the target holder and frozen using liquid nitrogen.  
The aluminum target holder was placed on a cryogenic rotating assembly, which was 
maintained at a temperature of ~ 173 K using copper braids connected to a liquid 
nitrogen reservoir. The MAPLE chamber is then evacuated to a pressure of 10-4 Pa.  
Some of the samples were run with nitrogen gas purge into the sample chamber. The 
target was rotated at a rate of 0.4 Hz during film deposition. As a control, films were also 
prepared by drop casting in order to provide comparison data. 
For the deposition of the PDLLA/dexamethasone bilayer, we first deposited a 
layer of dexamethasone using 100,000 laser pulses and then deposited a layer of PDLLA 
using 40,000 laser shots.  The fluence for each material was maintained at 700 mJ/cm2.  
PDLLA and dexamethasone thin films were also prepared by drop casting in order to 
provide comparison data. 
2.2.3 Fourier Transform Infrared Spectroscopy 
Fourier transform infrared spectroscopy (FTIR) was used to analyze the bending 
and stretching of the chemical bonds within the PDLLA thin film, and to insure that no 
structural damage occurred during material transfer.  100 averaged scans were taken from 
a Bruker IFS/66 spectrometer with a 4 cm-1 resolution.  Each PDLLA MAPLE sample 
was deposited on ZnSe crystal, and, therefore, the background spectrum was taken on 
uncoated ZnSe.  The sample compartment was purged with dry air for at least 25 minutes 
prior to data recording to reduce the contribution of water vapor and carbon dioxide to 
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the resulting spectrum. The measurements were taken in transmission mode, and the 
range recorded was 4000-600 cm-1.   
2.2.4 X-ray Photoelectron Spectroscopy 
X-ray photoelectron spectroscopy data was acquired using a Surface Science 
Laboratories Model SSX-100 Small Spot ESCA Spectrometer containing a 
monochromatized Al K-alpha X-ray source. A SPI Model 9602 True Spot electron gun 
was used to help control specimen charging. Spectra were collected at a 400-800 µm 
diameter X-ray spot size using a spectrometer pass energy of 50-150 eV.  PDLLA C1s 
and O1s spectra were recorded.  
2.2.5 Atomic Force Microscopy 
Atomic force microscopy (AFM) experiments were performed to investigate the 
surface morphology of the polymer and drug thin films. All measurements were obtained 
with a PicoPlus atomic force microscope (Molecular Imaging, Tempe, AZ, USA) 
equipped with a scanning head providing a maximum scan range of 100 x 100 µm. 
Imaging was performed in contact mode using silicon nitride cantilevers (length: 200 µm; 
 nominal spring constant: 0.06 Nm-1) with integrated pyramidal tips (base: 4x4 µm2; 
height: 2.86 µm). The imaging rate was 1.5 Hz. 
2.2.6 Attenuated Total Reflection Fourier Transform Infrared Spectroscopy 
To characterize the chemical composition of dexamethasone deposited by 
MAPLE, attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR) 
was performed using a IR100 spectrometer (Thermal Electron Corporation, San Diego, 
CA). The samples were scanned 32 times in the range of 2000 to 1200 cm-1.  ATR-FTIR 
was performed on dexamethasone deposited substrates either by solvent casting or by 
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MAPLE deposition to determine if MAPLE deposition would alter the chemical structure 
of the drug. 
2.2.7 Microglia Cultures and Nitric Oxide Production 
Microglia were isolated from mixed primary glial cell cultures. Cells dissociated 
from neonatal Sprague-Dawley rat cerebral hemispheres were plated in 75 cm2 poly-L-
lysine coated tissue culture flasks (Fisher Scientific, Hampton, NH) at a density of one 
brain per flask in culture medium consisting of DMEM-F12 media (Invitrogen, Carlsbad, 
CA) supplemented with 20% fetal bovine serum and 1% penicillin/streptomycin.  After 
7-10 days, flasks were lightly shaken to release microglial cells into the media 
supernatant, and the floating microglia were subsequently spun down, and resuspended in 
DMEM-F12 media supplemented with 10% fetal bovine serum. The cells were seeded in 
96-well culture plates at a density of 3 × 104 cells per well.  Twenty-four hours after 
seeding, microglial cells were treated with 10-pg/ml lipopolysacchride (LPS) (Sigma 
Aldrich, St. Louis, MO) and the released dexamethasone diluted to a concentration of 0.5 
µg/ml for 48 hours. 
Nitric oxide (NO) production by the microglial cultures was determined by 
measuring the accumulated levels of nitrite in the supernatant with Griess reagent 
(Promega, Madison, WI).  Briefly, after stimulation with LPS for 48 h, 50 µl cell culture 
supernatant was incubated with 50 µl sulphanilamide and 50 µl NED for 10 min each at 
room temperature.  The optical density was measured at 540 nm using a microplate 
reader (Bio-Tek Instruments, Winooski, VT).  NO production with and without 
dexamethasone when activated by LPS was determined. 
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2.2.8 UV Spectrophotometry Dexamethasone Release 
PDLLA/dexamethasone bilayers were deposited on Si (100) wafers using 
MAPLE.  Following deposition, the PDLLA/dexamethasone bilayers were incubated in 
phosphate buffer solution (PBS) at 37°C.  Every 24 hours, the PBS was removed and 
replaced with fresh PBS.  The amount of dexamethasone released during each 24 h 
period was measured by UV spectrophotometry at 242 nm with a microplate reader. 
 
2.3 Results and Discussion 
Figure 7 compares the PDLLA FTIR spectra from the drop cast sample and a 
representative MAPLE thin film.  The drop cast and MAPLE films share numerous 
absorption peaks over the entire spectra.  More importantly, they share similar 
absorbance at the main absorption sites: 1095 cm-1(symmetric stretching of COC bond), 




Figure 7.  Fourier transform infrared spectra of dropcast and matrix assisted pulsed laser 
evaporation-deposited PDLLA thin films. The spectra were recorded in transmission 
mode. 
 
The XPS C1s spectrum of PDLLA is made up of C-H groups, C-O groups in ester 
linkages and C=O groups in ester linkages at approximately 285, 287 and 289 eV, 
respectively. [33]  In the MAPLE deposited PDLLA C1s XPS spectrum (Figure 8), the 
carbon concentrations of the C-H, C-O and C=O bonds, have been estimated by 
integrating the peak areas and represent 38.4, 30.1 and 31.4% of the C1s spectrum, 
respectively.  The concentrations seen in our PDLLA film are similar to those obtained in 
previous PDLLA XPS analysis. [34-5]  For the O1s PDLLA spectra shown in figure 9, 
the absorption peak is broken up into two components.  The O1s component at 532.6 eV 
corresponds to O=C bonding, while the peak at 534.1 eV represent O-C groups. The 
concentrations for the O=C and O-C components are 52 and 48 %, which is close to the 
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ideal 1:1 ratio.  Again, the peak positions and concentrations are similar to previously 
published data. [34-5] 
 
 
Figure 8.  C1s X-ray photoelectron spectrum of PDLLA, revealing peaks at 285, 287 and 
289 eV.  These peaks correspond to C-H, C-O and C=O, which correspond to 38.4, 30.1 




Figure 9.  O1s X-ray photoelectron spectrum of PDLLA.  The O1s component at 532.6 
eV and 534.1 eV correspond to O=C and O-C bonding, and represent 52 and 48 % of the 
total O1s area, respectively. 
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Figure 10 contains an atomic force micrograph of a PDLLA thin film prepared by 
MAPLE (laser fluence= 1 J/cm2).  Inset (b) contains a plot of the height profile.  Over the 
17 microns covered, the thin film height varied nearly 400 nm.  This sample, similar to 
the other PDLLA thin films, contained random height differentials between 200-600 nm.  
These small height differences can be associated to the random dispersing of desorbed 
polymer from the MAPLE target. A similar result was seen with the deposition of 
horseradish peroxidase via MAPLE where thin films maintained an average roughness of 




Figure 10.  Topography flattened atomic force micrograph of a MAPLE deposited 
PDLLA thin film (a), with a height profile (b). 
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A topography flattened AFM image of a dexamethasone coated MAPLE film is 
shown in Figure 11. Inset (b) contains a plot of the height profile.   Unlike the PDLLA 
films, dexamethasone has a unique surface topography.  Ring-like structures 2-10 µm in 
length are observed. These structures are better observed in the deflection flattened AFM 
micrograph (Figure 12) of the dexamethasone thin film seen in Figure 11.  These 
structures are caused by projection of small particles of the dexamethasone from the 
MAPLE target onto the substrate.  This phenomenon, known as target splashing, is 
similar to an effect seen in pulsed laser deposition. [36] 
 
 
Figure 11.  Topography flattened atomic force micrograph of MAPLE deposited 




Figure 12.  Deflection flattened atomic force micrograph of the MAPLE dexamethasone 
thin film. 
 
The IR spectra of dexamethasone thin films deposited by MAPLE and drop 
casting are shown in Figure 13.  Dexamethasone deposited by each method revealed three 
peak absorptions at or near 1720, 1660, and 1620 cm-1. The strong absorption at 1660 cm-
1 corresponds to the carbonyl group (C=O) seen in the dexamethasone molecule (Figure 
6).  Correspondence between the two curves indicates that MAPLE deposition did not 




Figure 13.  ATR-IR spectra of dexamethasone deposited on Si wafers by (A) drop 
casting, and (B) MAPLE. 
 
To further examine the effect of the MAPLE process on the bioactivity of 
dexamethasone, primary microglia were treated with LPS to elicit the inflammatory 
response of the cells.  Microglia were used because they are known to mediate the initial 
inflammatory response to brain injury for patients undergoing neural electrode insertion. 
As shown in figure 14, the dexamethasone that was released from the MAPLE-deposited 
sample effectively inhibited the production of the inflammatory molecule, nitric oxide, by 
reactive microglia.  This result indicates that the dexamethasone was still bioactive 
following MAPLE deposition.  
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Figure 14.  Effect of dexamethasone released from PDLLA/dexamethasone thin films.  
Microglia were treated with LPS and dexamethasone was released for 48 hours, 
inhibiting LPS-induced production of nitrite.  Cells without LPS treatment served as 
positive control.  Microglia subjected to LPS serum served as a negative control.  Data 
shown are the average ± S.E.M. (n=3).   *P < 0.05 compared with LPS-treated cultures. 
 
Figure 15 contrasts the drug release profile of MAPLE-deposited dexamethsone 
thin films and PDLLA/dexamethasone bilayers.  In the bare dexamethasone thin film 
sample, nearly 96% of the drug is released within the first 24 hours.  In the 
PDLLA/dexamethasone bilayer, the dexamethasone release is slowed by 23% as only 
73% of the dexamethasone is released in the first 24 hours.  Following the initial 24 
hours, the PDLLA protective layer prevents the rapid salvation of the dexamethasone 
layer and prolongs the dexamethasone disassociation.  Drug release in the 
PDLLA/dexamethasone bilayer was seen up to 8 days following sample loading.  The 
sustained release observed over days 2-8 is believed to be attributed to dexamethasone 
diffusion through the remaining PDLLA matrix.    
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Figure 15.  Mass release of dexamethasone from MAPLE deposited PDLLA 
dexamethasone bilayer. Data shown is average ± S.E.M. (n=3). 
 
The cumulative mass release of dexamethasone from the MAPLE-deposited 
bilayer is shown in Figure 16.  The mass release curve follows a near linear release of 
dexamethasone between the ranges of 4.9 to 6.7 µg.  In an ideal drug-delivery situation, 
the ideal drug release measure would fall between a range below systemic toxicity and 
above ineffective dosage.  For the MAPLE bilayer system, simply increasing or 
decreasing the number of laser pulses can vary the amount of drug deposited onto the 
medical implant.  A more delayed dexamethasone release may be achieved by depositing 
a thicker PDLLA layer onto the dexamethasone monolayer.  Using MAPLE, the resulting 
drug delivery profile (drug quantity and delivery kinetics) can be custom designed by 



















Figure 16.  Cumulative mass of dexamethasone released from MAPLE deposited 
PDLLA-dexamethasone bilayers.  Data shown is average ± S.E.M. (n=3).  The release 















Chapter 3. MDW Three-Dimensional Deposition of Neuroblasts 
3.1 Introduction 
Every year, patients are treated for degenerative or traumatic injury to the 
peripheral nervous system (PNS) and central nervous system (CNS).  Following injury, 
the adult PNS retains the capacity for regeneration; however, return of motor and sensory 
function is variable.  Repair of the CNS (brain and spinal cord) represents an even greater 
challenge, because these injuries often lead to an irreversible loss of function. Multiple 
regeneration obstacles are observed at peripheral nerve lesions, especially at gaps greater 
than one centimeter in width. Problems including apoptosis, degeneration of the distal 
stump, swelling of the proximal stump, and gaps between nerve stumps may occur.  The 
autologous nerve graft is the gold standard for treatment of peripheral nerve injury [37]; 
however, this technique requires invasive graft-harvesting surgeries and offers variable 
patient outcomes. Current research is focused on developing improved synthetic or 
hybrid natural-synthetic nerve scaffolds that can be used to guide nerve regeneration 
across the nerve lesion site. [38]  A number of different synthetic materials have been 
explored for use as nerve guidance channels, including bioresorbable polyesters (e.g., 
poly(glycolic acid)), [39] bioinert polymers (e.g., polyethylene), [40] and natural 
materials (e.g., collagen). [41]  
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Protein gels have been incorporated within nerve guidance channels in order to 
improve the rate and quality of nerve regeneration. Synthetic conduits filled with 
Matrigel®, a protein colloid containing collagen type IV, laminin, and 
glycosaminoglycans, has improved nerve lesion regeneration in adult rats. [40] Growth 
factor-secreting neuroglial cells have also been incorporated within the lumen of nerve 
guidance channels in order to improve regeneration.  For example, Schwann cells 
cultured within the lumen of semi-permeable guidance channels have been shown to 
improve nerve repair in adult rodents. [42]  However, little research has been performed 
on three-dimensionally depositing neurons or other cells within nerve regeneration 
conduits using direct writing techniques.  
Various direct writing techniques including inkjet printing and microstamping 
have previously been used to pattern neurons onto a two-dimensional substrate.  Sanjana 
and Fuller [43] used an ink-jet printer to fabricate patterns of rat hippocampal neurons 
and glia on two-dimensional substrates.  However, the deposited circular cell patterns 
were ~200 µm in diameter, and, therefore, do not maintain the precision needed to direct 
write cells into neural guidance tubes.  James et al., [44] used a microstamping technique, 
whereby poly-l-lysine (PL) is stamped onto two-dimensional electrode arrays and 
randomly dispersed rat hippocampal neurons preferentially attach to the PL.  
Microstamping offers better precision than ink-jet printing, but the stamping technique is 
limited by the un-alterable master stamp pattern.  In both cases, neurons were patterned 
with some precision, but neurons were only patterned on a two-dimensional plane.  
Overall, these techniques are not capable of three-dimensional cellular deposition nor are 
they capable of depositing individual cells.  Matrix assisted pulsed laser evaporation 
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direct write (MDW) has the capability to deposit neurons within a three-dimensional 
hydrogel as well as deposit individual neurons with microscale precision. [45]  For this 
reason, MDW may provide unique capabilities for neuron patterning in nerve 
regeneration conduits.  
Matrix assisted pulsed laser evaporation direct write is a variation of pulsed laser 
deposition, which is a physical vapor deposition technique commonly used for the 
deposition of ceramic thin films. A low energy excimer laser ablates a cell-seeded quartz 
disk, known as a ribbon, according to patterns programmed into computer aided design 
(CAD) software. The laser energy gently propels cells toward a precise location on the 
substrate. The resolution of the MDW technique is currently around 10 µm; this value is 
quite close to the dimensions of many human cells. We have successfully produced 
patterns of ceramics (e.g., hydroxyapatite) and mammalian cells (e.g., C2Cl2 myoblasts) 
using this direct writing process.  Laser-based direct write processes provide several 
advantages over solvent-based techniques, including: enhanced cell-substrate adhesion, 
deposition under ambient conditions, the amount of material transferred can be 
quantitatively determined, and multilayered structures can be prepared by serial ablation 
of several ribbons. 
Previous experiments using MDW focused on depositing arrays of various cells, 
including Chinese hamster ovary, [6] embryonal carcinoma, [18] rat cardiac, [1] and 
human osteoblast cells. [8]  In 2004, MDW was first used as a three-dimensional 
deposition tool. [46]  To create a three-dimensional construct, a two-dimensional cellular 
array was printed onto an extracellular matrix (ECM) substrate, the printed cells were 
covered with additional ECM and the process was repeated.  This process proved 
 30
effective and three dimensional patterns were generated.  However, this method is labor 
intensive and maintains the possibility of disruption of the patterned cells though the 
addition of extra layers of ECM.  In our research, we have streamlined this process by 
direct writing neuroblasts at varying depths directly into the extracellular matrix, which 
allows for one step three-dimensional deposition. 
We have demonstrated two- and three-dimensional deposition of B35 neuroblasts 
using matrix assisted pulsed laser evaporation direct write.  The transferred cells were 
observed with optical and confocal microscopy using TUNEL, α-tubulin, and DAPI 
nucleic acid immunostains.  In these experiments, we examined the following: (1) the 
ability of MDW to precisely control the penetration depth of neuroblast cells into gelled 
extracellular matrix, and (2) the behavior of MDW-deposited neuroblasts within the 
extracellular matrix. This novel cell transfer process may allow for the development of 
layered, heterogeneous, three-dimensional cell-seeded scaffolds for peripheral nerve 
repair. 
 
3.2 Materials and Methods 
3.2.1 Matrix Assisted Pulsed Laser Evaporation Direct Write 
A schematic of the MDW apparatus is shown in Figure 4.  The cells to be 
transferred are immersed within a laser-absorbing matrix and then coated onto a quartz 
disk.  This cell-seeded ribbon is positioned several millimeters away from a receiving 
substrate.  A focused laser pulse is directed at the backside of the ribbon using a UV 
microscope objective. The laser energy interacts with the cell-seeded matrix at the 
ribbon/matrix interface, and gently desorbs the matrix from the ribbon. The matrix 
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assisted pulsed laser evaporation-direct write plume exhibits a front velocity on the order 
of 100 km/s.  A computer program controls the ribbon motion using an XY transition 
stage. Two-dimensional patterning can be created by lateral and longitudinal movement 
of both the ribbon and the receiving substrate.  
3.2.2 Neuronal Culture and MDW Ribbon Creation  
B35 rat neuroblasts (ATCC, Manassas, VA) reproduced rapidly in culture.  After 
reaching 70% confluence in culture, B35 cells were trypsinized and then centrifuged for 5 
minutes at 3000 rpm.  The resulting cell pellet was collected and resuspended in 1 mL of 
culture medium (Dulbecco’s modified eagle medium (DMEM) supplemented with 10% 
fetal bovine serum and 1% streptomycin).  
The MDW B35 neuroblast-seeded ribbon solution was created by spin coating 
200 µL of 1:5 extracellular matrix/DMEM at 1000 rpm for 15 seconds on a 1” quartz 
disk. The ribbon was then placed in a 37° C incubator for 10 minutes.  A 1 mL cell 
suspension was pipetted onto the ECM/DMEM coated quartz disk, and incubated for 10-
15 minutes.  The incubated cell-seeded ribbon was then placed on the ribbon holder of 
the MDW system.  
3.2.3 Receiving Substrate 
Extracellular matrix (ECM) (ATCC, Manassas, VA) contains a mixture of 
insoluble basement membrane proteins (e.g., laminin, collagen IV, and fibronectin), 
proteoglycans, and glycosaminoglycans, which have been shown to support neuronal 
growth and promote axonal extension. [47-49]  In addition, ECM contains several growth 
factors that assist neuronal growth and proliferation, including TGF-ß, EGF, IGF-1, 
bFGF, and PDGF. [50]  
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To prepare the receiving substrate, a 50 µL aliquot of liquid ECM was pipetted 
onto a 1 cm diameter circular glass slide.  For two-dimensional neuroblast transfers, the 
ECM was polymerized onto the glass slide by incubating the ECM substrate at 37° C for 
15 minutes prior to neuroblast transfer.   For three-dimensional neuroblast deposition, the 
ECM coated substrate was exposed to the room temperature for one minute prior to 
neuroblast transfer.   
The receiving substrate was then positioned 700-2000 µm below the neuroblast-
seeded ribbon.  As illustrated in figure 1, an ArF laser (λ=193 nm, energy density=0.02-
0.08 J/cm2) was focused on the quartz disk; neuroblasts were transferred onto the 
extracellular matrix substrate in line or rectangle array patterns. Following deposition, the 
cell-seeded surface was placed in a 37° C incubator for 5-10 minutes in order to allow the 
ECM to partially polymerize around the embedded neurons.  Three milliliters of culture 
medium was added to the neuroblast-seeded surface. The neuroblast-seeded extracellular 
matrix substrates were then fixed in 10 % formalin at 24, 72, and 96 hours after cell 
transfer. 
3.2.4 Apoptosis Detection via TUNEL Staining 
 Apoptosis was detected using a terminal deoxynucleotidyl transferase (TdT)-
mediated deoxyuridine triphosphate (dUTP) nickend labeling (TUNEL) kit (Roche, 
Indianapolis, IN).  After the cells had been fixed, they were permeabilized with 0.1% 
triton at room temperature. The cells were then incubated in the TUNEL reaction mixture 
for 60 minutes at 37° C. The cell nuclei were next counterstained with DAPI nucleic acid 
stain (Molecular Probes, Eugene, OR) at 10µM for 5 minutes. The cells were examined 
using a Nikon E600 fluorescence microscope.  If the neuroblasts are apoptotic and 
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undergoing DNA breakage, the TUNEL staining colors the neuroblast nuclei red.  To 
quantify the number of apoptotic cells, we counted the number of red nuclei compared to 
blue nuclei (non-apoptotic neuroblasts) at 96 hours post-transfer.   
3.2.5 Characterization of Neuronal Morphology in the 3-D ECM Gel 
B35 neuroblast morphology was examined using α-tubulin immunofluorescence 
staining. The fixed samples were washed and incubated in PBS containing 4% goat 
serum in order to block non-specific binding. Immunostaining of neuroblast cells was 
performed for one hour at room temperature with mouse monoclonal anti-α-tubulin 
(Sigma, St. Louis, MO) diluted 1:200. The cells were rinsed in 0.5% triton in PBS, and 
incubated for an hour at room temperature with goat anti-mouse IgG1 antibody 
conjugated with Alexa Fluor 488 (Molecular Probes, Eugene, OR) diluted 1:100 with 
0.5% triton in PBS.  
Cell nuclei were stained by incubating the samples with nuclear 4’,6-diamidino-2-
phenylindole, dihydrochloride (DAPI, Molecular Probes, Eugene, OR). The samples 
were mounted on glass microscope slides with Fluoromount-G (Southern Biotechnology 
Associates, Birmingham, Alabama). The immunostained cells were examined using a 
Zeiss Axiovert 200M inverted microscope and a Zeiss LSM 510 confocal microscope.   
Immunofluorescence staining was also used to measure the number of neuroblast 
axonal extensions over time.  We defined a B35 neuroblast axonal projection as an axon 
extended greater than one cell diameter.  The number of axonal projections were 
quantified at 24, 48, and 72 hours post-transfer.  As a comparative control for the MDW 
transferred neuroblasts, additional neuroblasts were plated onto a cell culture flasks 
coated with ECM.   
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3.2.6 Live/Dead Assay 
A live/dead cell staining kit (Biovision, Mountain View, CA) was used to stain 
the transferred neuroblasts.  Neuroblasts were transferred at 0.02 J/cm2 onto ECM coated 
quartz disks and staining was performed at 24, 48 and 72 post-transfer.  The staining 
solution was pipetted over the ECM and the solution was allowed to incubate for 15 
minutes.  Within the solution, the propidium iodide fluoresced dead cells red, and the 
Live-dyeTM stained live nuclei green.  The stained neuroblasts were viewed with an 
inverted optical microscope and a digital still camera with an epi-fluorescence 
attachment.  As a comparative control for the MDW transferred neuroblasts, additional 
neuroblasts were plated onto a cell culture flasks coated with ECM.    
 
3.3 Results and Discussion 
TUNEL staining was performed on the cells 96 hours after laser transfer in order 
to determine whether the MDW UV-laser transfer process caused neuroblast apoptosis. 
This staining process can detect cells that have undergone DNA breakage.  Only 3% of 
the transferred neuroblasts were apoptotic.  A representative TUNEL staining image is 
shown in Figure 17 where there are no red nuclei are visible, indicating that no DNA 
breakage has occurred.  Although ultraviolet laser light has the potential to significantly 
damage DNA bonding, these results suggest that MDW laser transfer does not 
significantly induce cellular apoptosis.  These results further prove previously published 
reports by Ringeisen et al. that suggest the laser transfer of cells via MDW does not 
induce apopotosis. [18] Their Comet assay, which measured the amount of cells with 
single and double strand DNA breakage, showed that pluripotent embryonal carcinoma 
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cells deposited by MDW did not have significantly more DNA breakage (due to 
apoptosis) than their control.   
 
 
Figure 17.  TUNEL staining of transferred B35 neuroblasts.  The cells were fixed 96 
hours after laser transfer. All cell nuclei counterstained with DAPI nucleic acid stain 
(blue).   No DNA breakage is observed (red). 
 
Figure 18 gives a comparative study of axonal projections of neuroblasts 
transferred by MDW onto ECM versus neuroblasts cultured on polystyrene culture flasks 
coated with ECM.  In both MDW transferred neuroblasts and the control neuroblasts, the 
number of axonal projections gradually increased over time with no significant difference 
between MDW-deposited and control neuroblasts.  Similarly, figure 19 reveals the 
live/dead analysis of neuroblasts transferred by MDW onto ECM versus neuroblasts 
cultured on polystyrene culture flasks coated with ECM.   The percentage of live cells 
transferred via MDW gradually increased over time while the control remained nearly 
constant at 100% viable.  Over the 72 hours studied, the MDW-transferred neuroblast 
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population recovered very close (6%) to control levels.  In both studies, transferred 




























Figure 18.  Number of axonal projections over time for MDW-transferred  and control 
neuroblasts.  Each bar represents mean + STD.  Using a students t-test, we found that p > 





























Figure 19.  Percentage of live neuroblasts deposited by MDW vs. control.  Each bar 
represents mean + STD.  Using a students t-test, we found that  p > 0.05, proving that the 
MDW transferred neuroblast data was similar to control. 
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We initially performed two-dimensional cell transfer of B35 neuroblasts to 
examine the neuroblast morphology after laser transfer. The B35 neuroblasts exhibited a 
flattened configuration on the ECM surface 24 hours after MDW cell transfer (Figure 
20(a)). At that time, the cells began to develop axonal processes within the ECM 
substrate plane. As indicated by Figure 18, the approximate number of axonal processes 
for MDW transferred cells was 1.4 +/- 0.4, which is similar to the control neuroblasts (1.7 
+/- 0.6).  Figure 20(b) depicts the transferred cells 72 hours after deposition.  Similarly to 
the 24 hour samples, the MDW transferred neuroblasts maintained a similar number of 
axonal projections (2.3 +/- 0.3) as the control (2.5 +/- 0.4).  This further proves that the 
MDW laser transfer of neuroblasts does not significantly impair the neuroblasts ability to 
produce axonal projections.  The transferred neuroblasts appear to have established 
robust axonal connections.  In localized areas, some neuroblasts have formed small two-
dimensional networks. Overall, these transfer experiments demonstrate that MDW-
transferred B35 neuroblasts create axonal extensions on the polymerized ECM surface in 






Figure 20. (a) Two-dimensional optical micrograph of B35 neuroblast patterns 24 hours 
after MDW transfer.  The deposited neuroblasts can be seen extending axons over the 
two-dimensional plane of the extracellular matrix surface.  (b) Two-dimensional optical 
micrograph of B35 neuroblast patterns 72 hours after MDW transfer.  The neuroblasts 
have extended their axons to form local neural networks. 
 
Quartz disks were used to attenuate the incident laser beam prior to interaction 
with the cell-seeded ribbon; this process allows precise control over laser fluence. At 
higher laser fluences, the neuroblasts were transferred to greater depths within the 
extracellular matrix substrate.  However, at higher laser fluences, the number of live 
transferred cells decreases.  We found that the percentage of neuroblasts that do not 
survive transfer quickly increases at fluences larger than 0.08 J/cm2.  Neuroblasts 
subjected to higher laser energies will either be photolysed or ruptured upon impact with 
the ECM due to the increased velocity and subsequent stresses.  Therefore, we define the 
depth of penetration maximum as the specific depth to which the transferred neuroblasts 
are deposited using the maximum safe laser fluence.  The depth of penetration maximum 
value for neuroblasts within gelled ECM was found at 75 µm with an applied fluence of 
0.08 J/cm2.   
Figure 21 contains a confocal image of the deposited neuroblasts 75 µm below the 
surface, which were subjected to a 0.08 J/cm2 laser fluence. The axonal extensions of B35 
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neuroblasts transferred to this depth are similar to those observed in neuroblasts 
transferred in a two-dimensional pattern on the ECM surface (Figure 20).  The successful 
deposition of neuroblasts 75 µm below the ECM allows for the construction of 
neuroblast-embedded ECM sheets.  These polymerized three-dimensional sheets can be 
stacked on top of each other to form larger three-dimensional structures or can be rolled 
and can be placed within the lumen of nerve guidance channels. 
 
 
Figure 21.  Confocal micrograph of the B35 neuroblasts 75 µm below the extracellular 
matrix surface 24 hours after MDW transfer. The neuroblasts have extended their axons 
throughout the three-dimensional ECM network. 
 
B35 neuroblasts were transferred to several depths within an extracellular matrix 
substrate in order to demonstrate the capabilities of this novel depth-controlled laser 
transfer process. We initially deposited neuroblasts inside the liquid/gel extracellular 
matrix using the highest fluence capable of transferring neuroblasts without significantly 
damaging the neuroblasts (0.08 J/cm2).  A second neuroblast layer was deposited directly 
on top of this initial level by attenuating the laser beam and lowering the fluence to 0.05 
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J/cm2.  A third neuroblast array was deposited directly on top of the second array by 
further attenuating the laser beam and lowering the fluence to 0.02 J/cm2; this laser 
fluence transferred cells to the extracellular matrix surface.  Figure 22 is a three-
dimensional confocal image of this three-dimensional neuroblast array.  The laser 
transferred neuroblasts exhibit axonal extensions within the 0, 45 and 75 µm- deep 
deposition planes, similar to those observed in two-dimensional neuroblast-seeded 
scaffolds.   In addition, axonal processes have formed between neuroblasts in different 
deposition planes within the porous extracellular matrix.   
 
 
Figure 22.  Confocal micrograph of transferred B35 neuroblasts within the extracellular 
matrix. Axonal extensions were observed between neuroblasts on different deposition 
planes, which were spaced 30-40 µm apart. 
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Figure 23.  Neuroblast penetration depth (µm) vs. applied laser fluence (J/cm2). 
The non-linear effect of applied laser fluence on neuroblast penetration depth is clearly 
observed. 
 
The penetration of the laser-transferred neuroblast cells within the extracellular 
matrix substrate is determined by the laser transfer velocity of trypsinized neuroblasts and 
the viscosity of the extracellular matrix. The physical properties of extracellular matrix 
have a significant effect on neuroblast penetration depth; ECM is a liquid from –6 to 4 °C 
system, and spontaneously polymerizes into a gelled stated above that temperature.  The 
viscous force of this Newtonian fluid is proportional to the product of the viscosity and 
the velocity for a rigid sphere. The value for viscous force is given by Stokes’ law as: 
 
F = 6 π η r v         [1] 
 
in which r is the radius of the sphere and v is the velocity of the sphere.  Figure 23 
includes neuroblast depth penetration values measured at three different laser fluences.  
The non-linear effect of applied laser fluence on neuroblast penetration depth is clearly 
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observed. Finally, it should be noted that the MDW process exposes the trypsinized 
neural cells to significant acceleration/deceleration and shear forces.  The penetration 
depth may have a practical limit beyond which acceleration/deceleration and shear will 





















Chapter 4. Conclusions and Future Directions 
Healthcare consumers continue to demand ever more complex tools for diagnosis 
and treatment of medical conditions. In the coming decades, implantable sensors, drug 
delivery devices, and artificial tissues will become significant instruments for medical 
care. Lasers have demonstrated unique capabilities for thin film processing: direct 
writing, cutting, and microfabrication of materials used in medical devices. We anticipate 
that laser processing of microdevices, nanodevices, and tissue engineered materials will 
be increasingly more significant in the coming years. 
There are a wide variety of applications for polymeric and biological thin films in 
the electronic, microsensor, pharmaceutical and bioengineering industries.  Solvent-based 
coating technologies, such as spin-coating, dip-coating and drop-casting, can result in 
inhomogeneous films with difficult thickness control.  Vapor deposition techniques are 
too damaging to delicate organic and polymeric materials.  Physical vapor deposition 
techniques, such as sputtering or plasma bombardment have the advantage of controlled 
layer-by-layer deposition, but they would irreversibly destroy the starting material.  
MAPLE is a thin film deposition technique capable of depositing a wide array of fragile 
organic materials without damaging the depositing material or disrupting its chemical 
structure.   MAPLE maintains the attributes of a dry physical vapor deposition technique, 
such as PVD, but it maintains the fragile material in a solvated state.  The MAPLE 
process deposits a micro-scale smooth thin film, while allowing thickness control by 
altering the matrix concentration, solvent type, and fluence.  
I have explored the use of MAPLE for the deposition of a dexamethasone/PDLLA 
drug delivery coating for use on medical implants.  MAPLE deposited thin films are 
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superior to films deposited by solvent casting methods because they are free of any 
residual solvent, which may be harmful to the patient after implantation.   
Experimentally, XPS and IR spectroscopy proved that both the PDLLA and 
dexamethasone thin films were not chemical damaged as compared to a drop cast thin 
film.  AFM revealed that both films maintained micro-scale smoothness with structures 
averaging only hundreds of nanometers in height. A nitric oxide bioactivity assay ensured 
that the bioactivity of the dexamethasone was maintained post-transfer.  The 
dexamethasone release from PDLLA/dexamethasone bilayers exhibited a large release 
over the first 24 hours (73%), which can be attributed to bulk degradation of the PDLLA.  
The drug-delivery bilayer exhibited diffusion controlled release over days 2-8, before 
completely exhausting the pharmaceutical.   
The PDLLA experiment proved that MAPLE could be utilized as a powerful tool 
in drug delivery design.  MAPLE deposits thin films in a linear fashion, corresponding to 
the number of applied laser pulses; and, therefore, it can be designed to specifically tailor 
necessary drug delivery release profiles.  Future studies will focus on drug delivery 
coatings with specific release profiles using different biodegradable polymers and 
different layering conformations.  The successful deposition of these films could lead the 
way to the development of more sophisticated, multilayer structures.  Future multilayer 
structures could include polymer, drug, growth factor, or antibiotic thin film layers.  
Depending on the implant application, MAPLE has the capability to deposit any 
combination of fragile organic materials.  
Many direct writing techniques were designed to rapidly construct prototype 
conformal electronic devices such as interconnects, resistors, and capacitors.  Laser 
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processing techniques such as LIFT and MDW are able to rapidly prototype these devices 
through ablation or desorption of material from a ribbon, via laser pulses, onto a 
receiving substrate. Of these two processes, MDW is a gentler method of direct writing 
because it uses a solvent to desorb the depositing materials from the ribbon.  The MDW 
process has numerous advantages over other controlled deposition techniques, including: 
CAD/CAM transfer at a rate of 1m/s, transfer under ambient conditions, and 10 µm 
resolution.  The main advantage of MDW is the ability to transfer a wide range of 
materials including inorganics, organics, polymers, living cells, enzymes, antibodies, and 
DNA. 
We have demonstrated in situ depth-controlled neuroblast transfer within 
extracellular matrix (ECM) material. Two-dimensional and three-dimensional neuroblast 
depositions were performed onto and within an extracellular matrix scaffold. Spatial 
localization of the transferred cells was controlled by varying laser transfer energy and 
extracellular matrix solidification.  By attenuating the laser energy during transfer, we 
were able to pattern cells at three different depths (0, 45, and 75 µm) below an ECM gel 
surface.  The results obtained indicate that MDW transfer can provide a unique approach 
for fabricating heterogeneous, layered, three-dimensional cell-seeded scaffolds.  
Neuroblasts were used in this experiment in the hope that this process can be 
applied to construction of seeded ECM lined neural tube conduits.  The computer control 
of the MDW system can theoretically mirror the cellular arrangement of neurons on the 
injured or severed nerve and help to further guide axons within the tube by forming 
connections between the severed nerve stumps.  We are investigating use of the MDW 
system to design and fabricate individually tailored cell-seeded scaffolds that precisely 
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correspond to lesion site geometry. In this way, MDW can be used to treat peripheral 
nerve injury. 
 MDW has a large potential for growth in the field of tissue engineering.  MDW is 
capable of depositing tissue scaffold material, living cells and the growth factors needed 
to induce tissue formation.  Combining these techniques could lead to the rapid 
fabrication of three-dimensional tissue constructs, which would revolutionize the 
biotechnology, medicine and fundamental cell biology research.  MDW has limitless 
potential and it is only a matter of time before this process is used to rapidly construct 
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